WSU's $80M Pharma and Biomed Building to Emphasize PGx, Expand Omics Capacity | GenomeWeb

NEW YORK (GenomeWeb News) – Washington State University today will officially open a new Pharmaceutical and Biomedical Sciences building, a $78.6 million facility that will house integrated drug, pharmacogenomics, genomics, imaging, and proteomics research programs and core labs.

The 125,000 square-foot facility in Spokane will also house the College of Pharmacy and will be home to much of the university's biomedical research programs, including resources and staff that are in the process of relocating to the building from WSU's campus in Pullman.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.